Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Metabolic syndrome, lipodystrophy, Impaired cognition...
View:
Post by scarlet1967 on Dec 14, 2023 7:50pm

Metabolic syndrome, lipodystrophy, Impaired cognition...

"Among 518 studied participants, two-thirds were females, and the mean age of the study population was 45 years (SD=11). The mean duration of cART was 10 years (SD=4). Median CD4 count was 460 cells/mm3. The prevalence of MetS according to the Adult Treatment Panel III (2005) criteria was 37.6%...

The prevalence of lipodystrophy was 23.6%..."

 

https://bmjopen.bmj.com/content/bmjopen/13/12/e069637.full.pdf

 

The interesting parts are mean age was 45 years and mean duration on antivirals 10 years so we are not talking about aging PLWH who have been treated for decades also their treatment with antivirals has been efficient as their CD4 counts are well above the 200 cells/mm2 threshold. Yet the prevalence of metabolic syndrome was about 38 percent(higher risk for heart diseases among others)and as for lipodystrophy(a metabolic disease )about 1 of 4 patients suffered from the condition. Admittedly there are many variables which need to be considered between these studies but the general idea is the reality that HIV and some combination therapies are responsible for serious medical conditions which need to be addressed if not prevented.

Tesamorelin improves the metabolic profile of HIV patients and treat lipodystrophy so the sooner HIV patients get started on the drug the better HIV care.

Another issue with PLWH is the fact that they are at high risk of impaired cognition add to that the below:

 

"Our results showed that people living with HIV who had NASH with significant activity and liver fibrosis had higher odds of having cognitive impairment compared with their counterparts without these conditions,” Dr. Han says. The results “underscore the necessity for increased attention to cognition among people with HIV who are receiving long-term care,” he continues."

https://www.physiciansweekly.com/liver-disease-further-impairs-cognition-in-patients-with-hiv/

 

It's worth mentioning that the prevalence of NASH/liver fibrosis are much higher among PLWH than general population!

 

"Based on biopsy studies, prevalence of NASH and significant liver fibrosis (stage ≥F2 on histology) was 48.77% (95% CI, 34.30%-63.34%) and 23.34% (95% CI, 14.98%-32.75%), respectively. Traditional metabolic syndrome and HIV-related factors were associated with NAFLD in PLWH."

https://pubmed.ncbi.nlm.nih.gov/36642292/

 

It's also worth mentioning that Tesamorelin is currently investigated for impaired cognition among PLWH! As for NASH I could keep going but I think that has been covered   many times before. Ignoring some of these conditions which can be prevented only will be resulting in dysfunctional and suboptimal medical care for a group of relatively uneducated patients who have to deal with not only a serious and potentially deadly disease but also the burden of added mental and physical stress because of the co- morbidities .The sale team with the support of the MSLs need to make serious efforts highlighting the issues to the patients and their caregivers and there is no room for inexcusable incompetency/failures despite all these new ongoing nformation which only should add to the therapeutic value of the drug thus easier sale for folks with " capabilities".

Comment by Mannequin on Dec 14, 2023 8:26pm
That's all wonderful information. However, have you ever ever heard the sales team or executive team say these things? And do we know the sales team even knows this information and is capable of delivering the message so that it's aleffective and increases sales??????  
Comment by Trogarzon on Dec 14, 2023 8:46pm
The post from Mannequin person decribes perfectly the issue with the company.  It's the worst managed company I have ever come upon.  Total imcompetence.  I hope Soleus does somthing about it because I don't beleive anyone overthere can do anything to improve the situation.  They have products, sales, pipeline, accrued losses, cash to pay their dept to the Shylock.  ...more  
Comment by Mannequin on Dec 15, 2023 8:40am
Under no circumstances do I want the company sold. I want results for 1902 to be good and will risk waiting for that result. I want clear communication as well.  I want an executed plan and no more BSwords.  
Comment by Trogarzon on Dec 15, 2023 10:04am
It does make sense that they leave shareholders in total darkness.  They proably want every one of them to take a hike and sell their shares for tax loss 2023.  That way they can continue doing what they've been doing quietly and brag about the 100% return since last deal with their new shareholders.  Like a said a big finger to everyone that hold a share before that day.  ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities